242 related articles for article (PubMed ID: 23258611)
1. A novel interaction of nucleophosmin with BCL2-associated X protein regulating death evasion and drug sensitivity in human hepatoma cells.
Lo SJ; Fan LC; Tsai YF; Lin KY; Huang HL; Wang TH; Liu H; Chen TC; Huang SF; Chang CJ; Lin YJ; Yung BY; Hsieh SY
Hepatology; 2013 May; 57(5):1893-905. PubMed ID: 23258611
[TBL] [Abstract][Full Text] [Related]
2. Upregulated expression of Nucleostemin/GNL3 is associated with poor prognosis and Sorafenib Resistance in Hepatocellular Carcinoma.
Hua L; Hu B; Yan D; Liu J; Shen Y; Zhao F; Shen C; Chen B; Cui X
Pathol Res Pract; 2017 Jun; 213(6):688-697. PubMed ID: 28476378
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and chemotherapy: the role of p53.
Brito AF; Abrantes AM; Pinto-Costa C; Gomes AR; Mamede AC; Casalta-Lopes J; Gonçalves AC; Sarmento-Ribeiro AB; Tralhão JG; Botelho MF
Chemotherapy; 2012; 58(5):381-6. PubMed ID: 23257706
[TBL] [Abstract][Full Text] [Related]
4. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
Miao J; Chen GG; Chun SY; Chak EC; Lai PB
Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
[TBL] [Abstract][Full Text] [Related]
5. Selective ablation of Notch3 in HCC enhances doxorubicin's death promoting effect by a p53 dependent mechanism.
Giovannini C; Gramantieri L; Chieco P; Minguzzi M; Lago F; Pianetti S; Ramazzotti E; Marcu KB; Bolondi L
J Hepatol; 2009 May; 50(5):969-79. PubMed ID: 19304334
[TBL] [Abstract][Full Text] [Related]
6. The expression of genes involved in hepatocellular carcinoma chemoresistance is affected by mitochondrial genome depletion.
Gonzalez-Sanchez E; Marin JJ; Perez MJ
Mol Pharm; 2014 Jun; 11(6):1856-68. PubMed ID: 24824514
[TBL] [Abstract][Full Text] [Related]
7. Ibulocydine sensitizes human hepatocellular carcinoma cells to TRAIL-induced apoptosis via calpain-mediated Bax cleavage.
Park SS; Jwa E; Shin SH; Ju EJ; Park I; Pak JH; Hwang JJ; Cho DH; Kim BM; Kim SB; Lee JS; Song SY; Jeong SY; Choi EK
Int J Biochem Cell Biol; 2017 Feb; 83():47-55. PubMed ID: 27923747
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
[TBL] [Abstract][Full Text] [Related]
9. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53-, Bcl-2- and caspase-dependent signaling pathway in xanthorrhizol-induced apoptosis of HepG2 hepatoma cells.
Handayani T; Sakinah S; Nallappan M; Pihie AH
Anticancer Res; 2007; 27(2):965-71. PubMed ID: 17465228
[TBL] [Abstract][Full Text] [Related]
11. Dioscin suppresses hepatocellular carcinoma tumor growth by inducing apoptosis and regulation of TP53, BAX, BCL2 and cleaved CASP3.
Zhang G; Zeng X; Zhang R; Liu J; Zhang W; Zhao Y; Zhang X; Wu Z; Tan Y; Wu Y; Du B
Phytomedicine; 2016 Nov; 23(12):1329-1336. PubMed ID: 27765352
[TBL] [Abstract][Full Text] [Related]
12. Activation of v-Myb avian myeloblastosis viral oncogene homolog-like2 (MYBL2)-LIN9 complex contributes to human hepatocarcinogenesis and identifies a subset of hepatocellular carcinoma with mutant p53.
Calvisi DF; Simile MM; Ladu S; Frau M; Evert M; Tomasi ML; Demartis MI; Daino L; Seddaiu MA; Brozzetti S; Feo F; Pascale RM
Hepatology; 2011 Apr; 53(4):1226-36. PubMed ID: 21480327
[TBL] [Abstract][Full Text] [Related]
13. Anticancer drugs are synergistic with freezing in induction of apoptosis in HCC cells.
Yuan F; Zhou W; Zhang J; Zhang Z; Zou C; Huang L; Zhang Y; Dai Z
Cryobiology; 2008 Aug; 57(1):60-5. PubMed ID: 18586021
[TBL] [Abstract][Full Text] [Related]
14. Different levels of p53 induced either apoptosis or cell cycle arrest in a doxycycline-regulated hepatocellular carcinoma cell line in vitro.
Lai PB; Chi TY; Chen GG
Apoptosis; 2007 Feb; 12(2):387-93. PubMed ID: 17191126
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
Wang X; Bai H; Zhang X; Liu J; Cao P; Liao N; Zhang W; Wang Z; Hai C
Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial cholesterol contributes to chemotherapy resistance in hepatocellular carcinoma.
Montero J; Morales A; Llacuna L; Lluis JM; Terrones O; Basañez G; Antonsson B; Prieto J; García-Ruiz C; Colell A; Fernández-Checa JC
Cancer Res; 2008 Jul; 68(13):5246-56. PubMed ID: 18593925
[TBL] [Abstract][Full Text] [Related]
17. Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.
Chen KF; Yu HC; Liu TH; Lee SS; Chen PJ; Cheng AL
J Hepatol; 2010 Jan; 52(1):88-95. PubMed ID: 19913321
[TBL] [Abstract][Full Text] [Related]
18. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
[TBL] [Abstract][Full Text] [Related]
19. SIRT6 Overexpression Potentiates Apoptosis Evasion in Hepatocellular Carcinoma via BCL2-Associated X Protein-Dependent Apoptotic Pathway.
Ran LK; Chen Y; Zhang ZZ; Tao NN; Ren JH; Zhou L; Tang H; Chen X; Chen K; Li WY; Huang AL; Chen J
Clin Cancer Res; 2016 Jul; 22(13):3372-82. PubMed ID: 26861461
[TBL] [Abstract][Full Text] [Related]
20. Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas.
Lee J
Arch Pharm Res; 2010 Sep; 33(9):1401-9. PubMed ID: 20945139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]